Article
Radiosensitization of NET cells by HSP90 inhibitor ganetespib is mediated through pleiotropic stress responses
2025-09-11
Abstract excerpt
<title>Abstract</title> <p> Background Peptide receptor radionuclide therapy (PRRT) employing [ <sup>177</sup> Lu]Lu-[DOTA-Tyr <sup>3</sup> ]octreotate has been established as treatment for patients with metastatic neuroendocrine tumors (NETs) that overexpress the somatostatin receptor (SSTR). While PRRT improves survival and quality of life, curative responses remain rare. One way to enhance PRRT efficacy i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ef63c1f-51fb-5071-823d-dc60421f99e3
- DOI
- 10.21203/rs.3.rs-7271457/v1
